Fujian Aonong Biological Technology Group Incorporation Ltd (603363) - Total Liabilities
Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has total liabilities worth CN¥5.47 Billion CNY (≈ $800.59 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603363 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Fujian Aonong Biological Technology Group Incorporation Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Fujian Aonong Biological Technology Grou asset portfolio.
Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Total Liabilities
The table below lists competitors of Fujian Aonong Biological Technology Group Incorporation Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TF Bank AB
ST:TFBANK
|
Sweden | Skr26.45 Billion |
|
Marcus & Millichap Inc
NYSE:MMI
|
USA | $186.88 Million |
|
MRC Global Inc
NYSE:MRC
|
USA | $1.26 Billion |
|
Tianjin Ringpu Bio Tech
SHE:300119
|
China | CN¥2.53 Billion |
|
Maoye Commercial Co Ltd
SHG:600828
|
China | CN¥10.53 Billion |
|
Guangdong South New Media Co Ltd
SHE:300770
|
China | CN¥1.16 Billion |
|
Avanos Medical Inc
NYSE:AVNS
|
USA | $268.00 Million |
|
Goldcup Electric Apparatus Co Ltd
SHE:002533
|
China | CN¥7.09 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Fujian Aonong Biological Technology Group Incorporation Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Fujian Aonong Biological Technology Grou (603363) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fujian Aonong Biological Technology Group Incorporation Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
The table below shows the annual total liabilities of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥5.16 Billion ≈ $755.32 Million |
-19.91% |
| 2024-12-31 | CN¥6.44 Billion ≈ $943.10 Million |
-54.38% |
| 2023-12-31 | CN¥14.13 Billion ≈ $2.07 Billion |
-7.22% |
| 2022-12-31 | CN¥15.23 Billion ≈ $2.23 Billion |
+2.15% |
| 2021-12-31 | CN¥14.91 Billion ≈ $2.18 Billion |
+83.69% |
| 2020-12-31 | CN¥8.12 Billion ≈ $1.19 Billion |
+123.07% |
| 2019-12-31 | CN¥3.64 Billion ≈ $532.37 Million |
+58.45% |
| 2018-12-31 | CN¥2.30 Billion ≈ $335.99 Million |
+46.01% |
| 2017-12-31 | CN¥1.57 Billion ≈ $230.11 Million |
+40.66% |
| 2016-12-31 | CN¥1.12 Billion ≈ $163.59 Million |
+23.83% |
| 2015-12-31 | CN¥902.85 Million ≈ $132.11 Million |
+26.82% |
| 2014-12-31 | CN¥711.92 Million ≈ $104.18 Million |
+17.85% |
| 2013-12-31 | CN¥604.09 Million ≈ $88.40 Million |
-- |
About Fujian Aonong Biological Technology Group Incorporation Ltd
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant, and other products; and operates pig breeding farms. The company also engages in the pig slaughtering … Read more